| Particulars |
|
|
|
|
Company Name
| Neuland Laboratories Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
12.83 |
B.V. (₹) |
1,453.60 |
| Sales(₹ Cr.) |
2,022.99 |
NP (₹ Cr.) |
360.22 |
| NP Var% |
108.00 |
Div% |
340.00 |
| CPS(₹) |
352.30 |
EPS (₹) |
280.80 |
| Traded Value(₹ Lakhs) |
465.84 |
52 Week High |
23,451.00 |
| 52 Week Low |
11,500.00 |
Price BSE |
23,222.00 |
| Price NSE |
23,207.00 |
Market Capital (₹ Cr.) |
29,793.76 |
| P/C Ratio |
65.90 |
P/E Ratio |
82.70 |
| Price Vs.BV |
15.98 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
641.58 |
| NP(₹ Cr.) |
147.36 |
NP Var % |
975.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
1,528.28 |
| OPM |
26.99 |
NP |
263.04 |
| NP Var% |
280.80 |
EPS |
387.19 |
| PE |
59.98 |
|
|